Microorganisms,
Год журнала:
2022,
Номер
10(9), С. 1727 - 1727
Опубликована: Авг. 27, 2022
Breast
cancer
(BC)
is
the
most
common
in
women
United
States.
There
has
been
an
increasing
incidence
and
decreasing
mortality
rate
of
BC
cases
over
past
several
decades.
Many
risk
factors
are
associated
with
BC,
such
as
diet,
aging,
personal
family
history,
obesity,
some
environmental
factors.
Recent
studies
have
shown
that
healthy
individuals
patients
different
microbiota
composition,
indicating
microbiome
a
new
factor
for
BC.
Gut
breast
alterations
prognosis.
This
review
will
evaluate
altered
populations
gut,
tissue,
milk
patients,
well
mechanisms
interactions
between
modulation
Probiotics
prebiotics
commercially
available
dietary
supplements
to
alleviate
side-effects
therapies.
They
also
shape
population
human
gut
microbiome.
evaluates
novel
means
modulating
by
nutritional
treatment
probiotics
emerging
promising
strategies
prevention
The
mechanistic
role
probiotic
partially
depend
on
estrogen
metabolism,
systematic
immune
regulation,
epigenetics
regulation.
Human Reproduction Update,
Год журнала:
2021,
Номер
28(1), С. 92 - 131
Опубликована: Сен. 30, 2021
Endometriosis
is
a
chronic,
burdensome
condition
that
historically
understudied.
Consequently,
there
lack
of
understanding
the
etiology
disease
and
its
associated
symptoms,
including
infertility
chronic
pelvic
pain
(CPP).
development
influenced
by
estrogen
metabolism
inflammation,
which
are
modulated
several
factors
microbiome
estrobolome
(the
collection
genes
encoding
estrogen-metabolizing
enzymes
in
gut
microbiome).
Therefore,
increasing
interest
role
microbiota
endometriosis
etiology.To
date,
no
cure
for
treatment
options
often
ineffective.
This
manuscript
will
review
potential
relationship
between
endometriosis,
CPP
highlight
available
data
on
relation
to
related
symptoms.
The
overarching
goal
this
inform
future
research
lead
deeper
possible
diagnostic
modalities
treatments.
impact
regulation
estrobolome,
as
well
inflammation
other
endometriosis-promoting
mechanisms
within
genital
tract,
be
reviewed.
methodological
limitations
microbiome-related
studies
critically
assessed
provide
improved
guidelines
clinical
studies.PubMed
databases
were
searched
using
following
keywords:
AND
microbiome,
IVF
(in-vitro
fertilization)
infertility.
Clinical
preclinical
animal
trials
eligible
review,
or
included.
All
manuscripts
published
2002-2021.In
total,
28
6
included
review.
In
both
human
studies,
bacteria
enriched
groups,
although
was
clear
consensus
specific
compositions
with
endometriosis.
However,
bacterial
vaginosis-associated
Lactobacillus
depletion
cervicovaginal
majority
(23/28)
studies.
Interpretation
endometrial
limited
owing
variety
factors,
discussed
addition,
metadata
outlining
antibiotic
usage,
age,
race/ethnicity,
menopausal
status
timing
sample
diagnosis
not
consistently
reported.
Animal
(6/6)
support
bidirectional
onset
progression.There
evidence
dysbiotic
multiple
gynecologic
conditions,
mounting
supporting
an
association
These
microbiomes
likely
play
gut-brain
axis,
further
supports
putative
spectrum
symptoms
CPP.
Collectively,
highlights
demand
more
rigorous
transparent
methodology
controls,
consistency
across
field,
inclusion
key
demographic
characteristics
comparison
participants.
Rigorous
study
designs
allow
better
disorders
female
reproductive
tract.
A
growing
amount
of
evidence
has
supported
that
gut
microbiota
plays
a
vital
role
in
the
reproductive
endocrine
system
throughout
woman's
whole
life,
and
microbial
β-glucuronidase
(gmGUS)
is
key
factor
regulating
host
estrogen
metabolism.
Moreover,
levels
also
influence
composition
as
well
diversity
microbiota.
In
normal
condition,
gmGUS-estrogen
crosstalk
maintains
body
homeostasis
physiological
level.
Once
this
broken,
metabolism
will
be
disturbed,
resulting
estrogen-related
diseases,
such
gynecological
cancers,
menopausal
syndrome,
etc.
together
with
dysbiosis,
which
may
accelerate
these
pathological
processes.
review,
we
highlight
regulatory
gmGUS
on
physical
summarize
present
interaction
between
metabolism,
unwrap
potential
mechanisms
behind
them.
Finally,
become
biomarker
for
early
diagnosis
estrogen-induced
diseases.
Regulating
activity
or
transplanting
gmGUS-producing
microbes
shows
promise
treating
Cancers,
Год журнала:
2023,
Номер
15(2), С. 443 - 443
Опубликована: Янв. 10, 2023
Breast
cancer
is
the
most
frequently
diagnosed
and
also
one
of
leading
causes
mortality
among
women.
The
genetic
environmental
factors
known
to
date
do
not
fully
explain
risk
developing
this
disease.
In
recent
years,
numerous
studies
have
highlighted
dual
role
gut
microbiota
in
preservation
host
health
development
different
pathologies,
them.
Our
capable
producing
metabolites
that
protect
homeostasis
but
can
produce
molecules
with
deleterious
effects,
which,
turn,
may
trigger
inflammation
carcinogenesis,
even
affect
immunotherapy.
purpose
review
describe
mechanisms
by
which
cause
general,
breast
particular,
compile
clinical
trials
address
alterations
or
changes
women
cancer.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(2), С. 1110 - 1110
Опубликована: Янв. 16, 2024
This
comprehensive
review
elucidates
the
profound
relationship
between
human
microbiome
and
breast
cancer
management.
Recent
findings
highlight
significance
of
microbial
alterations
in
tissue,
such
as
gut
breast,
their
role
influencing
risk,
development,
progression,
treatment
outcomes.
We
delve
into
how
can
modulate
systemic
inflammatory
responses
estrogen
levels,
thereby
impacting
initiation
therapeutic
drug
efficacy.
Furthermore,
we
explore
unique
diversity
within
indicating
potential
imbalances
brought
about
by
highlighting
specific
microbes
promising
targets.
Emphasizing
a
holistic
One
Health
approach,
this
underscores
importance
integrating
insights
from
human,
animal,
environmental
health
to
gain
deeper
understanding
complex
microbe-cancer
interplay.
As
field
advances,
strategic
manipulation
its
metabolites
presents
innovative
prospects
for
enhancement
diagnostics
therapeutics.
However,
rigorous
clinical
trials
remain
essential
confirm
microbiota-based
interventions
Frontiers in Cellular and Infection Microbiology,
Год журнала:
2020,
Номер
10
Опубликована: Ноя. 20, 2020
Human
milk
contains
a
dynamic
and
complex
site-specific
microbiome,
which
is
not
assembled
in
an
aleatory
way,
formed
by
organized
microbial
consortia
networks.
Presence
of
some
genera,
such
as
Staphylococcus,
Streptococcus,
Corynebacterium,
Cutibacterium
(formerly
known
Propionibacterium
),
Lactobacillus
,
Lactococcus
Bifidobacterium
has
been
detected
both
culture-dependent
culture-independent
approaches.
DNA
from
gut-associated
strict
anaerobes
also
repeatedly
found
studies
have
revealed
the
presence
cells
and/or
nucleic
acids
viruses,
archaea,
fungi
protozoa
human
milk.
Colostrum
microbes
are
transmitted
to
infant
and,
therefore,
they
among
first
colonizers
gut.
Still,
significance
gut
colonization
remains
open
question.
Clinical
trying
elucidate
question
confounded
profound
impact
non-microbial
components
intestinal
microecology.
Modifications
microbiota
may
biological
consequences
for
colonization,
metabolism,
immune
neuroendocrine
development,
mammary
health.
However,
factors
driving
differences
composition
microbiome
remain
poorly
known.
In
addition
colostrum
milk,
breast
tissue
lactating
non-lactating
women
contain
microbiota,
with
implications
pathogenesis
cancer
adverse
outcomes
associated
implants.
This
other
issues,
origin
current
limitations
future
prospects
addressed
this
review.
Foods,
Год журнала:
2021,
Номер
10(6), С. 1261 - 1261
Опубликована: Июнь 2, 2021
Gut
microbiota
is
a
group
of
microorganisms
that
are
deposited
throughout
the
entire
gastrointestinal
tract.
Currently,
thanks
to
genomic
tools,
studies
gut
have
pointed
towards
understanding
metabolism
important
bacteria
not
cultivable
and
their
relationship
with
human
homeostasis.
Alterations
in
composition
could
explain,
at
least
part,
some
epidemics,
such
as
diabetes
obesity.
Likewise,
dysbiosis
has
been
associated
disorders,
neurodegenerative
diseases,
even
cancer.
That
why
several
recently
focused
on
direct
these
types
conditions
specific
microbiota,
case
microbiota–intestine–brain
axis.
In
same
way,
control
related
diet.
Therefore,
this
review
highlights
importance
from
its
health–disease
condition,
well
emphasizes
effect
probiotic
prebiotic
consumption
balance
composition.
Biology,
Год журнала:
2022,
Номер
11(11), С. 1683 - 1683
Опубликована: Ноя. 21, 2022
The
possession
of
two
X
chromosomes
may
come
with
the
risk
various
illnesses,
females
are
more
likely
to
be
affected
by
osteoarthritis,
heart
disease,
and
anxiety.
Given
reported
correlations
between
gut
microbiome
dysbiosis
female
is
worthy
exploration.
Herein,
we
discuss
composition
microbiota
its
in
pathologies
affecting
population.
Using
PubMed,
performed
a
literature
search,
using
key
terms,
namely:
“gut
microbiome”,
“estrogen”,
“menopause”,
“polycystic
ovarian
syndrome”,
“pregnancy”,
“menstruation”.
In
polycystic
syndrome
(PCOS),
abundance
Bacteroides
vulgatus,
Firmicutes,
Streptococcus,
ratio
Escherichia/Shigella
was
found
increased
while
that
Tenericutes
ML615J-28,
124-7,
Akkermansia,
Ruminococcaceae,
Bacteroidetes
S24-7
reduced.
breast
cancer,
Clostridiales
enhanced,
cervical
Prevotella,
Porphyromonas,
Dialister
were
enhanced
but
Bacteroides,
Alistipes,
members
Lachnospiracea,
decreased.
Prevotella
increased.
Interestingly,
administration
Lactobacillus
acidophilus,
Bifidobacterium
bifidum,
reuteri,
fermentum
ameliorated
PCOS
symptoms
mix
lactis
W51,
bifidum
W23,
brevis
W63,
W52,
salivarius
W24,
acidophilus
W37,
Lactococcus
W19,
casei
W56,
W58
alleviated
vascular
malfunction
arterial
stiffness
obese
postmenopausal
women,
finally,
further
research
needed,
maybe
protective
against
bone
mass
loss.
As
several
studies
report
therapeutic
potential
probiotics
since
certain
pathological
states
has
been
relatively
characterized,
speculate
bacterial
species
as
warranted,
novel
independent
or
adjunct
therapies
for
pathologies.
Breast
cancer
(BC)
is
the
most
common
malignancy
in
women,
whom
it
reaches
20%
of
total
neoplasia
incidence.
Most
BCs
are
considered
sporadic
and
a
number
factors,
including
familiarity,
age,
hormonal
cycles
diet,
have
been
reported
to
be
BC
risk
factors.
Also
gut
microbiota
plays
role
breast
development.
In
fact,
its
imbalance
has
associated
various
human
diseases
although
consequential
cause-effect
phenomenon
never
proven.The
aim
this
work
was
characterize
tissue
microbiome
34
women
affected
by
using
an
NGS-based
method,
analyzing
tumoral
adjacent
non-tumoral
each
patient.The
healthy
tumor
tissues
differed
bacterial
composition
richness:
Amplicon
Sequence
Variants
(ASVs)
higher
than
(p
=
0.001).
Moreover,
our
analyses,
able
investigate
from
phylum
down
species
taxa
for
sample,
revealed
major
differences
two
richest
phyla,
namely,
Proteobacteria
Actinobacteria.
Notably,
levels
Actinobacteria
were,
respectively,
lower
with
respect
tissues.Our
study
provides
information
about
microbial
composition,
as
compared
very
closely
(paired
samples
within
same
woman);
found
such
possible
diagnostic
therapeutic
implications;
further
studies
necessary
clarify
if
simply
association
or
concausative
pathogenetic
effect
BC.
A
comparison
different
results
on
similar
seems
not
assess
universal
signature,
but
single
ones
depending
environmental
cohorts'
locations.
Polish Journal of Microbiology,
Год журнала:
2022,
Номер
71(2), С. 217 - 226
Опубликована: Май 31, 2022
Breast
cancer
(BC)
and
benign
breast
lesions
(BBLs)
are
common
diseases
in
women
worldwide.
The
gut
microbiota
plays
a
vital
role
regulating
diseases'
formation,
progression,
therapy
response.
Hence,
we
explored
the
structure
function
of
microflora
patients
with
BC
BBLs.
A
cohort
66
subjects
was
enrolled
study.
Twenty-six
had
BC,
20
BBLs,
matched
healthy
controls.
High
throughput
16S
ribosomal
RNA
(16S
rRNA)
gene
sequencing
technology
used
to
determine
microbial
community
structure.
Compared
individuals,
significantly
lower
alpha
diversity
indices
(Sobs
index,
p
=
0.019;
Chao1
0.033).
Sobs
were
also
BBLs
than
without
statistical
significance
(p
0.279,
0.314,
respectively).
Both
unweighted
weighted
UniFrac
analysis
showed
that
beta
differed
among
three
groups
3.376e-14,
<
0.001,
levels
Porphyromonas
Peptoniphilus
higher
0.004,
0.007,
respectively),
whereas
Escherichia
Lactobacillus
more
enriched
lesion
group
0.011,
Our
study
indicates
may
undergo
significant
changes
intestinal
microbiota.
These
findings
can
help
elucidate
flora
patients.